India’s medical device industry is entering one of the most important phases in its history. For decades, the country was recognised globally as a major pharmaceutical manufacturer, but its medical device sector remained comparatively small and heavily dependent on imported technology. That situation is now beginning to change.

Domestic companies are manufacturing a wider range of products, investment is increasing, exports are growing and Indian-made high-end equipment is gradually entering segments that were once almost entirely controlled by foreign manufacturers. At the same time, India still imports a large proportion of the medical devices it consumes, particularly advanced diagnostic, imaging and critical-care equipment.

In my opinion, the Indian medical device industry has strong long-term potential, but its future success will depend on whether the country can move beyond assembling imported components and build a complete ecosystem for research, components, manufacturing, clinical validation, regulatory compliance and after-sales service.

How Large Is the Indian Medical Device Industry?

There is no single universally accepted estimate of the size of India’s medical device market because different reports include different product categories. Some estimates place the industry at approximately US$14–15 billion in 2024–25.

The forecasts also vary. Invest India has reported that the sector could reach approximately US$30 billion by 2030, while a more recent projection cited by the India Brand Equity Foundation estimates that the market could reach about US$50 billion by 2030. These figures should therefore be viewed as a range rather than as a guaranteed outcome. Nevertheless, both forecasts point towards substantial expansion during the remainder of this decade. ,108 licensed medical device manufacturers** as of March 2026. These manufacturers operate across low-risk Class A products and higher-risk Class B, C and D devices. Some companies manufacture devices belonging to more than one risk category. manufacturing base shows that India is no longer limited to producing basic hospital supplies. The country now manufactures products ranging from consumables, surgical instruments and diagnostic reagents to implants, ultrasound systems, CT scanners, MRI-related equipment, mammography systems and radiotherapy machines.

Is the Current Growth Real?

The growth is real, but it must be viewed in the correct context.

India’s medical device exports increased from approximately US$2.92 billion in FY2021–22 to US$4.01 billion in FY2024–25. This represents average annual growth of roughly 11% over three years. Consumables and disposables formed the largest export segment in FY2024–25, followed by electromedical equipment, implants, in-vitro diagnostic reagents and surgical instruments. a imported medical devices worth approximately US$8.82 billion in FY2024–25. The government estimates that imports still account for around 60% of domestic medical device consumption. dia is simultaneously becoming a larger manufacturer and a larger consumer of imported devices. This is not necessarily a contradiction. Demand for healthcare technology is expanding quickly, and domestic production has not yet caught up in many advanced categories.

The real question is not whether the industry is growing. It clearly is. The more important question is whether domestic value addition is growing fast enough to reduce strategic dependence on imported components and finished equipment.

What Is Driving the Growth of the Indian Medical Device Industry?

Rising demand for healthcare

India’s large population, increasing healthcare awareness, expanding hospital infrastructure and growing use of diagnostic services are creating sustained demand for medical equipment.

Private hospitals are expanding beyond major metropolitan cities, while diagnostic centres, day-care facilities, speciality clinics and smaller nursing homes are adopting technologies that were previously limited to large hospitals.

Demand is also shifting from treatment-based healthcare towards early diagnosis, continuous monitoring and preventive care. This change is creating opportunities for diagnostic equipment, point-of-care testing, wearable devices, home-monitoring products and connected healthcare systems.

Insurance penetration and organised healthcare services are further increasing the number of patients who can access advanced procedures and diagnostic technologies. These factors are among the main reasons market researchers expect strong growth through 2030. t support for domestic manufacturing

The National Medical Devices Policy, 2023 provides a broader policy framework for developing the sector. It focuses on six principal areas:

regulatory streamlining, infrastructure development, research and innovation, investment, human-resource development, and international brand positioning. n Linked Incentive scheme for medical devices has an outlay of ₹3,420 crore and supports manufacturing in four important areas: cancer care and radiotherapy, radiology and imaging, anaesthesia and cardio-respiratory or renal-care equipment, and implants.

By July 2026, 27 applications had been approved under the scheme, including 14 applications from MSMEs. Approved projects had reported actual investment of approximately ₹1,153 crore and had begun domestic production of products such as MRI and CT equipment, linear accelerators, mammography systems, ultrasound equipment, C-arms, heart valves and stents. ficant because the programme is not limited to low-cost disposable products. It is encouraging Indian production in categories where the country has traditionally relied heavily on foreign manufacturers.

Development of medical device manufacturing parks

Three major medical device parks are under development in Uttar Pradesh, Madhya Pradesh and Tamil Nadu. These parks are intended to provide shared testing, sterilisation, warehousing, incubation, prototyping and other specialised facilities.

By July 2026, plots had been allotted to approximately 210 manufacturing units across the three parks. Shared infrastructure can be especially valuable for smaller companies that cannot independently invest in every laboratory, testing system or specialised facility required for compliant medical device manufacturing. g investment

Foreign direct investment in Indian MedTech activities totalled approximately ₹17,201 crore between FY2021–22 and FY2025–26. The sector permits up to 100% FDI through the automatic route for medical device manufacturing, making it accessible to international manufacturers seeking an Indian production base. one, however, should not be treated as the final measure of success. Its real value will depend on how much intellectual property, component production, engineering capability and skilled employment remain in India.

Where Are the Biggest Future Opportunities?

1. Import substitution in high-value medical equipment

The largest immediate opportunity lies in products that India imports in large quantities.

During FY2024–25, imports included approximately:

  • US$5.28 billion in electromedical equipment
  • US$915 million in in-vitro diagnostic products
  • US$640 million in implants
  • US$263 million in surgical instruments
  • US$1.72 billion in consumables and disposable products

l equipment alone represented the majority of the import value. This category includes many complex products such as imaging systems, monitoring equipment and technologically advanced hospital devices.

Indian manufacturers therefore have considerable opportunities in patient monitors, ventilators, anaesthesia workstations, ultrasound equipment, digital X-ray systems, dialysis products, critical-care systems and diagnostic platforms.

However, import substitution should not mean merely importing most components and carrying out final assembly in India. The larger opportunity is to manufacture key components, develop software, own product designs and control calibration, servicing and upgrades domestically.

2. Components and medical-grade materials

India’s medical device industry cannot become genuinely self-reliant without a strong component ecosystem.

Many manufacturers still depend on imported sensors, electronic modules, specialised motors, medical-grade polymers, imaging components, batteries, valves, precision tubing, semiconductors and testing equipment.

This creates opportunities for companies that may not manufacture complete medical devices but can produce reliable components for multiple device manufacturers.

A strong component industry would reduce lead times, foreign-exchange exposure and supply-chain risks. It would also allow Indian manufacturers to modify products more quickly for local clinical requirements.

3. Affordable devices for smaller cities and rural healthcare

A medical device designed for a premium hospital in Europe or the United States may not always suit a district hospital or small clinic in India.

India needs products that are affordable, durable, easy to maintain, energy efficient and capable of operating in environments where power supply, trained technicians or specialised infrastructure may be limited.

This presents an opportunity for Indian companies to develop:

  • Portable diagnostic equipment
  • Battery-operated devices
  • Point-of-care testing systems
  • Compact sterilisation equipment
  • Low-maintenance patient monitors
  • Telemedicine-compatible examination devices
  • Affordable maternal and neonatal-care products

The companies that understand these operational realities may create products suitable not only for India but also for Africa, Southeast Asia, Latin America and other cost-sensitive markets.

4. Home healthcare and remote monitoring

Healthcare is gradually moving beyond hospitals. Patients with diabetes, hypertension, respiratory conditions and cardiac disorders increasingly require long-term monitoring rather than occasional hospital visits.

This change is increasing the potential for blood-pressure monitors, pulse oximeters, glucose-monitoring systems, portable ECG devices, sleep-monitoring products, respiratory-care equipment and rehabilitation devices.

The larger commercial opportunity will not be limited to selling hardware. Companies will be able to combine devices with software platforms, patient records, alerts, subscriptions, maintenance and clinical-support services.

5. Medical device software and artificial intelligence

Software is becoming an essential component of modern healthcare technology. It may support diagnosis, analyse medical images, operate connected devices, calculate clinical parameters or help doctors monitor patients remotely.

India has a large software and engineering talent pool, which gives the country a natural advantage in this area. The opportunity includes standalone software as a medical device, artificial-intelligence-assisted diagnostics, cloud-connected monitoring systems and cybersecurity solutions for hospitals and devices.

Regulation is also becoming more structured. CDSCO published guidance on medical device software under the Medical Devices Rules, 2017, in July 2026. This indicates that software-based medical technologies are moving from a loosely understood area into a more clearly supervised regulatory environment. ering this field will need to treat clinical evidence, risk management, software validation, cybersecurity and post-market monitoring as seriously as physical manufacturing.

6. Contract manufacturing for global brands

India can become an important contract-manufacturing destination for international medical device companies.

The country offers engineering talent, a large domestic market, established pharmaceutical manufacturing experience and potentially competitive production costs. But medical device buyers evaluate more than price. They also examine quality systems, process validation, traceability, biocompatibility, sterilisation, packaging integrity and regulatory history.

Manufacturers that invest in internationally recognised quality systems and reliable documentation can serve global brands without immediately having to establish their own consumer-facing brand in every market.

Contract manufacturing may also help Indian companies gain experience in sophisticated processes before launching their own higher-value products.

7. Exporting affordable Indian medical technology

India’s export opportunity goes far beyond basic consumables.

Medical device exports increased to more than US$4 billion in FY2024–25, with particularly strong contributions from consumables, electromedical equipment and implants. elop a position similar to the one it achieved in pharmaceuticals: supplying reliable, affordable products to markets that find European, Japanese or American equipment too expensive.

To achieve this, manufacturers must build confidence in “Made in India” medical devices through consistent quality, international certifications, credible clinical evidence and dependable technical support.

A low price may help secure the first order, but product performance and after-sales service determine whether the customer returns.

What Are the Main Challenges?

Continued import dependence

Imports accounting for around 60% of consumption remain the clearest indication that domestic manufacturing has not yet reached its full potential. is particularly serious in high-value equipment and specialised components. Even when a finished device is assembled in India, a large share of its value may still come from imported electronics, sensors or subassemblies.

Limited research and development

Medical device development is expensive and slow. A manufacturer may need years of engineering work, testing, clinical investigation and regulatory review before earning meaningful revenue.

Many Indian manufacturers operate with limited R&D budgets and focus on products that are easier to reproduce. This approach may generate short-term sales, but it rarely creates defensible intellectual property or global leadership.

Testing and clinical validation

Medical devices must demonstrate safety and performance. Depending on the product, this may require electrical-safety testing, electromagnetic-compatibility testing, biocompatibility studies, sterilisation validation, software validation, stability studies and clinical investigations.

India is developing more shared testing facilities, but capacity, accessibility, cost and turnaround time remain important concerns for MSMEs.

Regulatory complexity

A stronger regulatory system is necessary for patient safety and international credibility. At the same time, unclear interpretations, changing requirements or inconsistent implementation can delay product development.

India now regulates medical devices under the Medical Devices Rules, 2017, with devices classified according to risk. All device categories have progressively been brought within the licensing framework. quirement is not weaker regulation, but regulation that is predictable, transparent, technically competent and aligned, where appropriate, with recognised international standards.

Quality perception

Indian manufacturers must overcome the assumption that locally manufactured products are chosen primarily because they are inexpensive.

The industry will build a stronger international reputation only when Indian products are consistently associated with reliability, thoughtful design, validated performance and responsive service.

This requires investment in quality management to become part of product development—not simply a documentation activity undertaken before an inspection.

Shortage of specialised skills

Medical devices combine medicine, mechanical engineering, electronics, materials science, software, industrial design and regulatory knowledge.

India produces large numbers of engineers and healthcare professionals, but relatively few people are trained to work across these disciplines. Greater collaboration among manufacturers, hospitals, universities, clinicians and biomedical engineers will therefore be essential.

What Should India Do Next?

India’s next phase of growth should focus on increasing domestic value rather than only increasing the number of factories.

First, policy support should encourage localisation of critical components and technologies. A medical device assembled from mostly imported components offers less strategic value than one whose design, software, electronics and major parts are developed domestically.

Second, government and hospital procurement should evaluate total value rather than choosing products only on the basis of the lowest initial price. Product life, maintenance cost, accuracy, downtime, consumable availability and after-sales support should be considered.

Third, shared testing and clinical-research infrastructure must become easier for MSMEs to access. A small manufacturer should not need to build every specialised facility independently.

Fourth, manufacturers should involve doctors, nurses, technicians and patients earlier in product development. Products designed without observing actual clinical use often fail because they solve an engineering problem rather than a healthcare problem.

Finally, Indian companies must think globally from the beginning. Export-ready documentation, risk management, quality systems, packaging, service manuals and regulatory strategy should be developed alongside the product—not added after domestic sales begin.

My Opinion on the Future of the Indian Medical Device Industry

I am optimistic about the future of the Indian medical device industry, but I do not believe growth is guaranteed simply because India has a large population or a lower manufacturing cost.

The strongest evidence of progress is that Indian production is entering advanced categories, exports have crossed US$4 billion, thousands of manufacturers are now licensed and major policies are supporting medical-device parks, research, components and domestic production. oncern is that India continues to import most of its high-value medical technology. Unless the country develops components, intellectual property, clinical evidence and international-quality brands, much of the future market growth may still benefit overseas manufacturers.

India’s greatest opportunity is not to become the cheapest manufacturer of existing products. It is to become the most capable developer of reliable, affordable and practical medical technology for countries with large populations and limited healthcare resources.

The next decade could establish India as a major global MedTech manufacturing and innovation centre. Achieving that position will require consistent regulation, long-term investment, stronger collaboration with clinicians and an uncompromising commitment to quality.

The opportunity is enormous. The outcome will depend on whether the industry chooses to compete only on price—or builds the technology, trust and quality required to compete on value.

Frequently Asked Questions

Is the Indian medical device industry growing?

Yes. Medical device exports increased from approximately US$2.92 billion in FY2021–22 to US$4.01 billion in FY2024–25. Domestic production of several advanced devices has also started under government-supported manufacturing programmes. of India’s medical device demand is met through imports?

According to the Government of India, imports account for approximately 60% of domestic medical device consumption. India imported medical devices worth about US$8.82 billion in FY2024–25. ical device segments offer the best opportunities in India?

Major opportunities include diagnostic imaging, patient monitoring, in-vitro diagnostics, implants, critical-care equipment, home-healthcare products, medical software, affordable rural-healthcare devices, components and contract manufacturing.

Can India become a global medical device manufacturing hub?

India has the market size, engineering talent and manufacturing experience required to become a major global hub. However, long-term success will depend on stronger domestic component production, research, regulatory capability, clinical validation, quality consistency and after-sales service.